Skip to main content

ADVERTISEMENT

comparative effectiveness study

Research in Review
06/03/2017
JCP Editors
Patients with non-small cell lung cancer (NSCLC) and synchronous brain metastasis demonstrate improved 1-year and 5-year overall survival (OS) after thoracic surgery and systemic chemotherapy, according to research...
Patients with non-small cell lung cancer (NSCLC) and synchronous brain metastasis demonstrate improved 1-year and 5-year overall survival (OS) after thoracic surgery and systemic chemotherapy, according to research...
...
06/03/2017
Journal of Clinical Pathways